Načítá se...
Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections
The rapid development of antimicrobial resistance is threatening mankind to such an extent that the World Health Organization expects more deaths from infections than from cancer in 2050 if current trends continue. To avoid this scenario, new classes of anti-infectives must urgently be developed. An...
Uloženo v:
| Vydáno v: | Beilstein J Org Chem |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Beilstein-Institut
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6204809/ https://ncbi.nlm.nih.gov/pubmed/30410623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3762/bjoc.14.239 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|